CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Roma, Italy and 197 other locations
of Evorpacept (ALX148) in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Patients With Advanced HER2-overexpressing gastric/GEJ adenocarcinoma...
Phase 2, Phase 3
Roma, Italy and 54 other locations
The purpose of the study is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of...
Phase 2
Rome, Italy and 15 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...
Phase 3
Roma, Italy and 219 other locations
This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...
Phase 3
Rome, Italy and 314 other locations
in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuva...
Phase 2, Phase 3
Terni, Umbria, Italy and 91 other locations
placebo plus chemotherapy as first-line (1L) therapy for locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma...
Phase 3
Roma, Italy and 150 other locations
adenocarcinoma in adult participants.The primary hypotheses of this study are that pembrolizumab plus chemotherapy is superior to placebo p...
Phase 3
Roma, Italy and 214 other locations
The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolum...
Phase 1, Phase 2
Roma, Italy and 46 other locations
This is an open-label, dose-escalation and dose-expansion study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy...
Phase 1
Rome, Italy and 33 other locations
Clinical trials
Research sites
Resources
Legal